Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thermochemotherapy with Cisplatin, Gemcitabine, and IFN-a in Advanced Cancers
NCT00178698Phase 2Unknown
- Sponsor
- UTHealth Houston
- Start
- Jul 2002
- Primary completion
- Jun 2013
- Modality
- Nanoparticles, Cytokines & Interferons, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Cisplatin micelle injection (HA132), gemcitabine, interferon alfa in small cell lung cancer (SCLC), neuroendocrine cancer, gastric cancer (GC), non-small cell lung cancer (NSCLC), sponsored by UTHealth Houston. Status: unknown.
02
Drugs
Cisplatin micelle injection (HA132)gemcitabineinterferon alfa
03
Conditions
small cell lung cancer (SCLC)neuroendocrine cancergastric cancer (GC)non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00178698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00178698.